Skip to main content

Table 1 ESCC patient characteristics (n = 84)

From: Identification of a serum-based miRNA signature for response of esophageal squamous cell carcinoma to neoadjuvant chemotherapy

Characteristics Value
Response to preoperative chemotherapy 0, 1/2, 3 69/15
Age Years 65 (30–77)
Sex F/M 14/70
cT 0/1/2/3/4 0/11/12/59/2
cN 0/1/2/3 10/47/23/4
cM 0/1 79/5
cStage 0/1/2/3/4 0/3/22/54/5
pT 0/1/2/3/4 4/23/19/29/9
pN 0/1/2/3 29/28/16/11
pM 0/1 79/5
pStage 0/1/2/3/4 2/17/27/33/5
Differentiationa Poor/moderate/well 10/59/8
Lymphatic invasion 0/1 31/53
Venous invasion 0/1 59/25
Pretreatment serum CEAb ng/ml 2.53 (1–6)
Pretreatment serum SCC antigenc ng/ml 1.46 (0.5–6.7)
  1. ESCC esophageal squamous cell carcinoma, CEA carcinoembryonic antigen, SCC squamous cell carcinoma
  2. aThere were seven cases without information of pathological differentiation
  3. bThere was one case without serum CEA value
  4. cThere was one case without serum SCC antigen value
\